Cargando…

TRIF as a Novel Modulator of Liver Inflammation and Fibrosis

Detalles Bibliográficos
Autor principal:	Török, Natalie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404095/ https://www.ncbi.nlm.nih.gov/pubmed/28462370 http://dx.doi.org/10.1016/j.jcmgh.2017.03.002

Ejemplares similares

TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice
por: Yang, Ling, et al.
Publicado: (2017)

Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes
por: Fan, Weiguo, et al.
Publicado: (2021)

Inhibition of TRIF-Dependent Inflammation Decelerates Afterload-Induced Myocardial Remodeling
por: Bettink, Stephanie I., et al.
Publicado: (2022)

TRIF Deficiency does not Affect Severity of Ovalbumin-induced Airway Inflammation in Mice
por: Kim, Tae-Hyoun, et al.
Publicado: (2014)

Retraction: TRIF/miR-34a mediates aldosterone-induced cardiac inflammation and remodeling
Publicado: (2021)

Modulation of Liver Inflammation and Fibrosis by Interleukin-37
por: Mountford, Steffeni, et al.
Publicado: (2021)

Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
por: Li, Yuan, et al.
Publicado: (2022)

Induction of TRIF- or MYD88-dependent pathways perturbs cell cycle regulation in pancreatic cancer
por: Zambirinis, Constantinos P., et al.
Publicado: (2013)

ZCCHC3 modulates TLR3-mediated signaling by promoting recruitment of TRIF to TLR3
por: Zang, Ru, et al.
Publicado: (2020)

Stem Cells, Inflammation, and Fibrosis
por: Volarevic, Vladislav, et al.
Publicado: (2016)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
por: Zheng, Shirong, et al.
Publicado: (2016)

Salmonella Suppresses the TRIF-Dependent Type I Interferon Response in Macrophages
por: Owen, Katherine A., et al.
Publicado: (2016)

Trif-dependent induction of Th17 immunity by lung dendritic cells
por: Hsia, Bethany J., et al.
Publicado: (2014)

The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice
por: Tsutsui, Hiroko, et al.
Publicado: (2010)

A Role for Extracellular Vesicles in Liver Fibrosis
por: Karp, Seth J.
Publicado: (2015)

Cystic Fibrosis: “Ionocyte Modulators”?
por: Shah, Viral S., et al.
Publicado: (2023)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)

A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses
por: Pryke, Kara M., et al.
Publicado: (2017)

Inflammation in Liver Diseases
por: Feng, Dechun, et al.
Publicado: (2018)

The Toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery
por: Leichtle, Anke, et al.
Publicado: (2009)

Modulation of Inflammation by Alcohol Exposure
por: Lehnert, Mark, et al.
Publicado: (2014)

Infection and Inflammation MUC up the Cystic Fibrosis Airway
por: Ma, Jonathan
Publicado: (2022)

FoxM1 Induces CCl2 Secretion From Hepatocytes Triggering Hepatic Inflammation, Injury, Fibrosis, and Liver Cancer
por: Filliol, Aveline, et al.
Publicado: (2020)

Pre‐clinical evidence of a dual NADPH oxidase 1/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis
por: Thannickal, Victor J., et al.
Publicado: (2023)

Liposomal Lipopolysaccharide Initiates TRIF-Dependent Signaling Pathway Independent of CD14
por: Watanabe, Sachiko, et al.
Publicado: (2013)

TRIF Is Required for TLR4 Mediated Adjuvant Effects on T Cell Clonal Expansion
por: Gandhapudi, Siva K., et al.
Publicado: (2013)

Beyond MyD88 and TRIF Pathways in Toll-Like Receptor Signaling
por: Piras, Vincent, et al.
Publicado: (2014)

TRIF signaling is required for caspase-11-dependent immune responses and lethality in sepsis
por: Tang, Yiting, et al.
Publicado: (2018)

The Future of Highly Effective Modulator Therapy in Cystic Fibrosis
por: Daines, Cori L., et al.
Publicado: (2021)

Identifying New Epigenetic Drivers of Liver Fibrosis
por: Argemi, Josepmaria, et al.
Publicado: (2018)

Metabolic Syndrome: A Warning Sign of Liver Fibrosis
por: Seo, Ji A
Publicado: (2022)

Hyperosmolarity impedes the cross-priming competence of dendritic cells in a TRIF-dependent manner
por: Popovic, Zoran V., et al.
Publicado: (2017)

Adaptive Evolution in TRIF Leads to Discordance between Human and Mouse Innate Immune Signaling
por: Hyland, Edel M, et al.
Publicado: (2021)

Both TLR2 and TRIF Contribute to Interferon-β Production during Listeria Infection
por: Aubry, Camille, et al.
Publicado: (2012)

CircTUBD1: A Novel Circular RNA Molecule as a Therapeutic Target in Radiation-induced Liver Fibrosis
por: Gu, Catherine Yujia, et al.
Publicado: (2022)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Liver regeneration and fibrosis after inflammation
por: Tanaka, Minoru, et al.
Publicado: (2016)

MAIT cells in liver inflammation and fibrosis
por: Mehta, Hema, et al.
Publicado: (2022)

Modulator treatment for people with cystic fibrosis: moving in the right direction
por: Elborn, J. Stuart
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gv9f97mq4dcg2age16h9f7injc